F or p e o p le w h o h a ve tro u b le fa llin g a s le e p a n d /o r s ta y in g a s le e p , o n ly A M B IE N CR h a s tw o la y e rs th a t a d d re s s b o th p ro b le m s : T h e firs t la y e r d is s o lv e s q u ic k ly to h e lp

yo u fa ll a s le e p fa s t, w h ile th e s e c o n d d is s o lv e s s lo w ly to h e lp yo u s ta y a s le e p , so you c a n w a k e u p re a d y fo r y o u r d a y.** A M B IE N CR c a n be ta k e n fo r a s lo n g a s y o u r

h e a lth c a re p ro v id e r re c o m m e n d s . A s k y o u r p r e s c r ib e r if A M B IE N CR is r ig h t f o r y o u .

For special offers and a

-Night free trial of AMBIEN CR visit: ambienCR.com/deals or call

.

.

.

.

A M B IE N CR is in d ic a te d to h e lp you fa ll a s le e p a n d /o r

s ta y a sle e p .

IM PO RTANT SAFETY IN FO R M ATIO N

A M B IE N CR is a tre a tm e n t o p tio n you a n d yo u r d o c to r

c a n c o n s id e r a lo n g w ith life s ty le c h a n g e s a n d c a n be

ta k e n fo r a s lo n g a s y o u r d o c to r re c o m m e n d s . U ntil

yo u k n o w h o w A M B irN CR w ill a ffe c t yo u , you

s h o u ld n ’t d riv e o r o p e ra te m a c h in e ry . Be s u re y o u ’re

a b le to d e v o te 7 to 8 h o u rs to s le e p b e fo re b e in g

a c tiv e a g a in . S le e p w a lk in g , a n d e a tin g o r d riv in g w h ile

n o t fu lly a w a k e , w ith a m n e s ia fo r th e e v e n t h a ve b e e n

re p o rte d . If you e x p e rie n c e a n y o f th e s e b e h a v io rs

c o n ta c t y o u r p ro v id e r im m e d ia te ly . In ra re c a s e s s le e p

a id s m a y c a u s e a lle rg ic re a c tio n s s u c h a s s w e llin g o f

y o u r to n g u e o r th ro a t o r s h o rtn e s s o f b re a th . If you

h a ve a n a lle rg ic re a c tio n w h ile u sin g A M B IE N CR,

c o n ta c t y o u r d o c to r im m e d ia te ly . S id e e ffe c ts m a y

in c lu d e n e xt d a y d ro w s in e s s , d iz z in e s s a n d h e a d a c h e .

It's n o n -n a rc o tic ; h o w e ve r, lik e m o s t s le e p m e d ic in e s

it h as so m e ris k o f dependency. D o n ’t ta ke it w ith alcohol.

A M B IE N is in d ic a te d fo r s h o rt-te rm tre a tm e n t to h e lp

yo u fall a s le e p .

IM PO R TA N T SAFETY IN FO R M ATIO N

W h e n you firs t s ta rt ta k in g A M B IE N , u se c a u tio n in

th e m o rn in g w h e n e n g a g in g in a c tiv itie s re q u irin g

c o m p le te a le rtn e s s u n til you k n o w h o w you w ill re a c t to

th is m e d ica tio n . In m o s t in sta n ce s, m e m o ry p ro b le m s

ca n b e avo id ed if you ta k e A M B IE N o n ly w h e n you are

a b le to g e t a fu ll n ig h t’s s le e p (7 to 8 h ours) b e fo re you

n e e d to b e a ctive a g a in. A s w ith a ny sle e p m e d ica tio n ,

d o n o t u se a lc o h o l w h ile you a re ta k in g AM B IE N .

S le e p w a lkin g , a n d e a tin g o r d rivin g w h ile n o t fu lly

a w a k e , w ith a m n e s ia fo r th e e ve n t, h a ve b e e n re p o rte d .

If you e xp e rie n ce a n y o f tfie s e b e h a vio rs c o n ta c t your

p ro v id e r im m e d ia te ly. In ra re ca se s, sle e p m e d ic in e s

m a y c a u s e a lle rg ic re a ctio n s su ch as sw e llin g o f yo u r

to n g u e o r th ro a t, s h o rtn e s s o f b re a th o r m o re severe

re su lts. If you have a n a lle rg ic re a ctio n w h ile u sin g

c o n ta c t y o u r d o c to r im m e d ia te ly. P re scrip tio n

s le e p a id s a re o fte n ta ke n fo r 7 to 1 0 d a ys - o r lo n g e r

a s a d vise d by yo u r provider. L ike m o s t s le e p m e d icin e s,

it h as so m e risk o f dependency. T here is a low o ccurrence

o f sid e e ffe c ts a sso cia te d w ith th e s h o rt te rm use o f

The m o s t c o m m o n ly o b s e rv e d sid e e ffe c ts in

co n tro lle d c lin ic a l tria ls w e re d ro w s in e s s (2% ),

d izzin e ss (1 % ), a n d d ia rrh e a (1 % ).

You a re e n c o u ra g e d to re p o rt n e g a tiv e s id e e ffe c ts

o f p re s c rip tio n d ru g s to th e FDA.

V is it w w w .fd a .g o v /m e d w a tc h o r 1 8 0 0 -F D A 1 0 8 8